April 2025 is officially here and the month has a lot going on. Here's a list of notable dates so you can know what to plan ...

Discover Celcuity's Q4 2024 insights: gedatolisib's promising trials for breast cancer, $2B market potential, and key 2025 milestones.

Year.Quarterly Net Income of $145,320.Full Year Revenue of $15.7 Million, Up 27% Year-Over-Year.Backlog of $54.4 Million, ...

Focus remains on completing the tailing filter electrical and mechanical installations and the pipeline connections between the upper and lower platforms. The Company plans to provide operational ...

The PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is on track to report topline data in Q2 2025VIKTORIA-2 Phase 3 remains on track to ...

Explore March's market turmoil: stocks plunge on tariff uncertainty, defensive sectors shine, recession risks rise, and Q2 ...

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Acuity Brands (AYI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW ...

Key US economic data releases, including JOLTS, ADP, and Non-Farm Payrolls, may trigger high volatility in crypto markets this week. New tariff announcements expected on April 2 could shock markets, ...